Numis Securities Reaffirms “Hold” Rating for Victrex (VCT)

Victrex (LON:VCT)‘s stock had its “hold” rating reaffirmed by equities research analysts at Numis Securities in a research note issued on Monday. They currently have a GBX 2,550 ($35.75) target price on the stock, up from their prior target price of GBX 2,300 ($32.25).

Other equities analysts have also recently issued reports about the stock. Liberum Capital raised their target price on shares of Victrex from GBX 2,440 ($34.21) to GBX 2,770 ($38.84) and gave the company a “buy” rating in a research note on Monday, December 11th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,600 ($36.46) target price on shares of Victrex in a research note on Tuesday, December 5th. Barclays cut their target price on shares of Victrex from GBX 2,350 ($32.95) to GBX 2,270 ($31.83) and set an “equal weight” rating for the company in a research note on Tuesday, November 28th. Peel Hunt cut shares of Victrex to a “hold” rating and set a GBX 2,300 ($32.25) target price for the company. in a research note on Tuesday, October 31st. Finally, Deutsche Bank reaffirmed a “hold” rating and set a GBX 2,200 ($30.85) target price on shares of Victrex in a research note on Thursday, January 4th. Eight analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of GBX 2,368.80 ($33.21).

Victrex (LON:VCT) opened at GBX 2,550 ($35.75) on Monday. The firm has a market cap of $2,090.00 and a price-to-earnings ratio of 2,198.28. Victrex has a 52 week low of GBX 1,826 ($25.60) and a 52 week high of GBX 2,772 ($38.87).

In other Victrex news, insider Martin Court sold 441 shares of the stock in a transaction on Friday, December 15th. The shares were sold at an average price of GBX 2,618 ($36.71), for a total transaction of £11,545.38 ($16,188.14). Insiders have acquired 14 shares of company stock valued at $36,018 in the last quarter.

WARNING: This story was reported by American Banking News and is owned by of American Banking News. If you are reading this story on another website, it was copied illegally and reposted in violation of US and international copyright & trademark legislation. The original version of this story can be accessed at

Victrex Company Profile

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with's FREE daily email newsletter.

Leave a Reply